Addus HomeCare Co. (NASDAQ:ADUS) Stock Position Lowered by Public Employees Retirement Association of Colorado

Public Employees Retirement Association of Colorado decreased its position in Addus HomeCare Co. (NASDAQ:ADUS) by 21.9% in the second quarter, according to its most recent 13F filing with the SEC. The firm owned 2,410 shares of the company’s stock after selling 675 shares during the period. Public Employees Retirement Association of Colorado’s holdings in Addus HomeCare were worth $280,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Ellsworth Advisors LLC acquired a new stake in shares of Addus HomeCare in the second quarter worth $598,000. Dean Capital Management purchased a new position in Addus HomeCare during the 4th quarter valued at about $652,000. Quadrature Capital Ltd purchased a new position in Addus HomeCare during the 1st quarter valued at about $1,557,000. Lord Abbett & CO. LLC acquired a new position in shares of Addus HomeCare in the 1st quarter valued at about $8,274,000. Finally, Vanguard Group Inc. lifted its position in shares of Addus HomeCare by 3.2% in the fourth quarter. Vanguard Group Inc. now owns 1,257,440 shares of the company’s stock worth $116,753,000 after purchasing an additional 38,876 shares in the last quarter. 95.35% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Addus HomeCare

In other Addus HomeCare news, EVP Michael D. Wattenbarger sold 21,917 shares of the business’s stock in a transaction on Monday, August 26th. The shares were sold at an average price of $133.29, for a total transaction of $2,921,316.93. Following the completion of the transaction, the executive vice president now owns 7,215 shares of the company’s stock, valued at approximately $961,687.35. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In other news, Director Esteban Lopez sold 500 shares of the firm’s stock in a transaction on Tuesday, September 10th. The shares were sold at an average price of $127.50, for a total value of $63,750.00. Following the sale, the director now owns 3,366 shares in the company, valued at $429,165. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, EVP Michael D. Wattenbarger sold 21,917 shares of the company’s stock in a transaction on Monday, August 26th. The shares were sold at an average price of $133.29, for a total transaction of $2,921,316.93. Following the transaction, the executive vice president now owns 7,215 shares of the company’s stock, valued at $961,687.35. The disclosure for this sale can be found here. In the last three months, insiders have sold 22,917 shares of company stock worth $3,050,082. 4.60% of the stock is owned by insiders.

Addus HomeCare Stock Performance

ADUS opened at $130.95 on Friday. The company has a market cap of $2.37 billion, a PE ratio of 32.49, a price-to-earnings-growth ratio of 2.40 and a beta of 1.04. The stock has a 50-day moving average of $128.25 and a 200-day moving average of $115.31. Addus HomeCare Co. has a 52-week low of $78.35 and a 52-week high of $136.12.

Addus HomeCare (NASDAQ:ADUS) last announced its earnings results on Monday, August 5th. The company reported $1.35 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.21 by $0.14. Addus HomeCare had a return on equity of 9.81% and a net margin of 6.18%. The firm had revenue of $286.90 million during the quarter, compared to analysts’ expectations of $284.90 million. During the same quarter in the prior year, the business earned $0.94 earnings per share. The company’s revenue was up 10.4% on a year-over-year basis. On average, research analysts predict that Addus HomeCare Co. will post 4.58 earnings per share for the current year.

Wall Street Analyst Weigh In

Several research analysts have weighed in on the stock. StockNews.com lowered shares of Addus HomeCare from a “strong-buy” rating to a “buy” rating in a research note on Sunday, July 7th. Macquarie began coverage on shares of Addus HomeCare in a research note on Friday, June 28th. They issued an “outperform” rating and a $136.00 price target on the stock. Oppenheimer lifted their price objective on Addus HomeCare from $140.00 to $145.00 and gave the company an “outperform” rating in a research report on Monday, September 23rd. Stephens reaffirmed an “overweight” rating and issued a $138.00 target price on shares of Addus HomeCare in a research report on Tuesday, August 6th. Finally, TD Cowen lifted their price target on Addus HomeCare from $128.00 to $137.00 and gave the company a “buy” rating in a report on Thursday, August 8th. One research analyst has rated the stock with a sell rating and eight have assigned a buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $128.29.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.